Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
Philip LaTourette, Sita Awasthi, Angela Desmond, Norbert Pardi, Gary H. Cohen, Drew Weissman, Harvey M. Friedman
Topics & Concepts
VirologyHerpes simplex virusNeutralizing antibodyImmunizationAntibodyBiologyImmunologyVirusMedicineHerpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus researchVirus-based gene therapy research